Bioascent Is A Prominent Provider Of Integrated Drug Discovery Servicesestablished In 2013 And Located In Newhousescotlandthe Company Focuses On Maximizing Drug Discovery Success For Its Clients By Offering A Comprehensive Range Of Services That Span From Initial Project Stages To Preclinical And Clinical Candidates The Services Provided By Bioascent Include De Novo Assay Developmenttarget Analysisbespoke Screening Strategieshigh Throughput And Fragment Screeningmedicinal And Synthetic Chemistrycomputational Chemistryand Compound Managementthe Company Manages A Large Library Of Over 1 5 Million Compounds And Offers The Compound Cloud Servicewhich Provides Rapid Online Access To A Diverse Collection Of High Quality Compoundsbioascent Operates From A State Of The Art Facility Equipped With Advanced Laboratories And Technologiesreinforcing Its Commitment To Excellence In Drug Discovery
